Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Cardioembolic Stroke.

Kamel H, Healey JS.

Circ Res. 2017 Feb 3;120(3):514-526. doi: 10.1161/CIRCRESAHA.116.308407. Review.

PMID:
28154101
2.

Poorly recognized age-related downward deviation of the inguinal ligament.

Nawaz Y, Barvalia M, Rana G, Khakwani MZ, Azim K, Patel R, Idrees S, Baker G, Cohen M, Wasty N.

SAGE Open Med. 2016 Oct 25;4:2050312116675565. eCollection 2016.

3.
4.
5.

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.

Fahrni G, Wolfrum M, De Maria GL, Banning AP, Benedetto U, Kharbanda RK.

J Am Heart Assoc. 2016 Jul 22;5(7). pii: e003515. doi: 10.1161/JAHA.116.003515.

6.

Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy.

Kinnaird T, Butt M, Abdul F, Yazji K, Hailan A, Gallagher S, Ossei-Gerning N, Chase A, Choudhury A, Smith D, Anderson R.

PLoS One. 2016 Jun 30;11(6):e0157812. doi: 10.1371/journal.pone.0157812. eCollection 2016.

7.

Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent Registry.

Valle JA, Shetterly S, Maddox TM, Ho PM, Bradley SM, Sandhu A, Magid D, Tsai TT.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003519. doi: 10.1161/CIRCINTERVENTIONS.115.003519.

PMID:
27301394
9.

Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.

Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, McCabe JM, Resnic FS, Gurm HS, Yeh RW.

Circ Cardiovasc Interv. 2016 Apr;9(4):e003464. doi: 10.1161/CIRCINTERVENTIONS.115.003464.

10.

Systematic Review and Meta-Analysis of Major Cardiovascular Outcomes for Radial Versus Femoral Access in Patients With Acute Coronary Syndrome.

Ruiz-Rodriguez E, Asfour A, Lolay G, Ziada KM, Abdel-Latif AK.

South Med J. 2016 Jan;109(1):61-76. doi: 10.14423/SMJ.0000000000000404. Review.

11.

Effect of enoxaparin on clinical events after percutaneous coronary intervention.

Tang N, Chen S, Shi X, Ye Z, Zheng X.

Int J Clin Exp Med. 2015 Jul 15;8(7):10815-24. eCollection 2015.

13.

Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index.

Dobies DR, Barber KR, Cohoon AL.

Open Heart. 2015 Feb 10;2(1):e000088. doi: 10.1136/openhrt-2014-000088. eCollection 2015.

14.

Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury.

Tsai MS, Chou SE, Lai HS, Jeng LB, Lin CL, Kao CH.

Medicine (Baltimore). 2015 Mar;94(9):e610. doi: 10.1097/MD.0000000000000610.

15.

Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes.

Ortiz D, Jahangir A, Singh M, Allaqaband S, Bajwa TK, Mewissen MW.

Circ Cardiovasc Interv. 2014 Dec;7(6):821-8. doi: 10.1161/CIRCINTERVENTIONS.114.001306. Epub 2014 Nov 11.

16.

Primary angioplasty in the ACCEPT registry: Why has it been difficult to accept and implement the radial artery access as preferential?

Siqueira DA, Brito FS Jr, Abizaid AA.

Arq Bras Cardiol. 2014 Oct;103(4):268-71. English, Portuguese. No abstract available.

17.

Interaction between access choice and pharmacotherapy for coronary intervention: the results of a UK survey.

Kinnaird TD, Ossei-Gerning N, Mitra R, Anderson RA.

Open Heart. 2014 Jun 13;1(1):e000094. doi: 10.1136/openhrt-2014-000094. eCollection 2014.

18.

Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis.

Kwok CS, Rao SV, Myint PK, Keavney B, Nolan J, Ludman PF, de Belder MA, Loke YK, Mamas MA.

Open Heart. 2014 Feb 13;1(1):e000021. doi: 10.1136/openhrt-2013-000021. eCollection 2014.

19.

Main complications of mild induced hypothermia after cardiac arrest: a review article.

Soleimanpour H, Rahmani F, Golzari SE, Safari S.

J Cardiovasc Thorac Res. 2014;6(1):1-8. doi: 10.5681/jcvtr.2014.001. Epub 2014 Mar 21.

20.

Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE study.

Zhang L, Li Y, Jing QM, Wang XZ, Ma YY, Wang G, Xu B, Gao RL, Han YL; CREATE Investigators..

J Interv Cardiol. 2014 Apr;27(2):119-26. doi: 10.1111/joic.12104. Epub 2014 Mar 12.

Supplemental Content

Support Center